LLY
ELI LILLY & CO
Health Care·Pharmaceuticals·UNITED STATES
$1,149.36
MCap $1T
as of 2026-09-04
Total
A3w
Fund
A3w
Quant
A10w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-09-04
MIDOS SI
+0.03
Sentiment 41.4%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$1,149.36
Adaptive Mean
$1,148.63
+0.73 vs mean
Adaptive σ
12.07
MIDOS BB
$1,124.49 – $1,172.78
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-09-04
Composite Z
+0.45
ROE
102.3%
Z +2.07
Rev Gr
47.7%
Z +0.17
EPS Gr
26.2%
Z +0.29
OPM Gr
9.1%
Z +0.02
FCF Yld
1.1%
Z +0.15
EPS Surp
0.3%
Z +0.15
EPS 3mo Δ
40.6%
Z +0.26
Fwd P/E
24.32
Z —
PEGY
0.28
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-09-04
Q3M
2.25
Q6M
4.19
Q12M
7.10
MA 30/100
1.075
Bullish (MA30 > MA100)
α (Jensen)
0.1194
β (12M)
0.35
σ (12M)
0.356
Divergence — Fundamentals vs Momentum
Z Percentile
91%
Q Percentile
89%
Divergence
+1.3
Tier
ALIGNED
Fundamentals and momentum roughly in line.
Kirkpatrick RS & Persistence
RS
1.0
RS Pctl
62%
RS Decile
D7
Persistence
3w
at grade A
Options / OI Analysis
as of 2026-08-10
OI Center
$1,060.59
-12.7% from spot
Max Pain
$1,175.00
PCR (OI)
1.16
neutral
Skew
-0.35
OI Composite
-1
neutral
Direction
strong_bearish